New recurrent UTI guideline: What urologists need to know
WEBOct 7, 2019 · The index patient is an otherwise healthy adult female with an uncomplicated, culture-proven recurrent UTI associated with acute-onset symptoms. Central to a diagnosis of UTI is the symptom of dysuria. Dysuria is a highly specific symptom, with more than 90% accuracy for UTI in young women in the absence of concomitant vaginal irritation or ...
Urology Times | News & Insights for Urologists & Health …
WEBBy Gopal H. Badlani, MD. September 19th 2024. "A global consensus on standardization of terminology, separation of LUTS vs pain for outcome, HL positivity and negativity, markers for disease, and the role of new interventions for local vs systemic therapy is needed," writes Gopal H. Badlani, MD.
Shock wave therapy: ED cure or unproven treatment? - Urology …
WEBAug 6, 2019 · Low-intensity extracorporeal shock wave therapy is a safe treatment for men with erectile dysfunction and might work to improve, or even cure, ED in some patients. But there remain important unanswered questions, including which patients are ideal candidates and which protocol and devices are best. Without answers, offering the ED treatment ...
Transgender surgery: Videos demonstrate cutting-edge techniques
WEBApr 6, 2017 · Miroslav L. Djordjevic, MD, PhD, is professor of urology and surgery at the School of Medicine, University of Belgrade, Serbia. In this video, we demonstrate our technique and special considerations for orchiectomy in transgender patients. Principles include use of a vertical midline scrotal incision and maximal preservation of underlying ...
Dr. Elterman discusses Rezum and Aquablation for patients with BPH
WEBSep 10, 2021 · At the 2021 American Urological Association annual meeting, Dean Elterman, MD, MSc, FRCSC, presented the studies “Rezūm water vapor therapy for large volume (≥80 mL) benign prostatic enlargement: large, multi-center cohort,” 1 and “Pooled analysis of bladder function post-Aquablation.” 2 In these studies, the Rezum water vapor and Aquablation benign prostatic hyperplasia (BPH ...
AUGS Position Statement: Vaginal Pessary Use and Management …
WEBFeb 19, 2024 · The purpose of this clinical consensus statement is to identify areas of expert consensus and nonconsensus regarding pessary fitting, follow-up, and management of pessary complications to improve the safety and quality of care where evidence is currently limited. Over the past 50 years, pessary use has increased in …
Long-term results of Rezum therapy for patients with large prostates
WEBDec 23, 2021 · So, the retreatment rate for our small prostate cohort was 4.4%, which is in line with the results demonstrated from the original WATER clinical trial, 3 which also had a retreatment rate of 4.4%. For our large prostate cohort, this subset of patients had a retreatment rate of 18.4%, so a little less than one in five patients required ...
Dr. Winter highlights the benefits of vaginal estrogen - Urology …
WEBNov 9, 2023 · Another really important thing is that all of the data that we have shows that vaginal estrogen doesn't increase the risk of blood clots. It's safe to use in somebody who with a history of blood clots, with a history of coronary artery disease, with a history of stroke. It's fine. It's also never been shown to cause breast or uterine cancer.
EpiSwitch Prostate Screening blood test launches on US market
WEBSep 26, 2023 · The EpiSwitch Prostate Screening (PSE) blood test has been clinically validated and is now available to men in the US who are being screened for prostate cancer, announced Oxford BioDynamics, the developer of the test, in a news release. 1. "It feels wholly appropriate that the early launch of the …
PSMA-PET Results Reporting and Interpretation - Urology Times
WEBNov 28, 2022 · EP: 8. PSMA-PET Results Reporting and Interpretation. EP: 9. PSMA-PET: Documentation of Patient Eligibility and Reimbursement. EP: 10. The Potential of Using Artificial Intelligence in PSMA-PET Results Interpretation. EP: 11. A Summary of Recent Advances and Remaining Unmet Needs in Targeted Prostate Cancer Imaging. EP: 12.